P

Inventor

PARKS CHRISTOPHER L

US19 patents
⚠️ This page may combine multiple inventors who share the name “PARKS CHRISTOPHER L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INT AIDS VACCINE INITIATIVE

14 patents
US9347065B2May 24, 2016

Methods to improve vector expression and genetic stability

INT AIDS VACCINE INITIATIVE7 citations78
US10894080B2Jan 19, 2021

Transgenic VERO-CD4/CCR5 cell line

INT AIDS VACCINE INITIATIVE0 citations59
US10844095B2Nov 24, 2020

Recombinant viral vectors

INT AIDS VACCINE INITIATIVE0 citations50
US10202424B2Feb 12, 2019

Recombinant viral vectors

INT AIDS VACCINE INITIATIVE0 citations50
US9802986B2Oct 31, 2017

Recombinant viral vectors

INT AIDS VACCINE INITIATIVE0 citations50
US10544430B2Jan 28, 2020

Vesicular stomatitis virus and virus rescue system

INT AIDS VACCINE INITIATIVE0 citations48
US10279027B2May 7, 2019

Transgenic Vero-CD4/CCR5 cell line

INT AIDS VACCINE INITIATIVE0 citations48
US9925258B2Mar 27, 2018

Replication-competent VSV-HIV Env vaccines

INT AIDS VACCINE INITIATIVE0 citations48
US9944935B2Apr 17, 2018

Methods to improve vector expression and genetic stability

INT AIDS VACCINE INITIATIVE0 citations46
US10792357B2Oct 6, 2020

Optimized HIV envelope gene and expression thereof

INT AIDS VACCINE INITIATIVE0 citations45
US10220087B2Mar 5, 2019

Optimized HIV envelope gene and expression thereof

INT AIDS VACCINE INITIATIVE0 citations45
US9562078B2Feb 7, 2017

Methods for identifying broadly neutralizing antibodies utilizing recombinant HIV-1 envelope glycoproteins comprising stabilizing mutations

INT AIDS VACCINE INITIATIVE0 citations44
US9402894B2Aug 2, 2016

Viral particles derived from an enveloped virus

INT AIDS VACCINE INITIATIVE0 citations44
US9610346B2Apr 4, 2017

Recombinant viral vectors

INT AIDS VACCINE INITIATIVE0 citations43

INT AIDS VACCINE INITIATIVE INC

3 patents

WYETH CORP

2 patents